GlassScriptPhysician profile
Jaime D Hernandez
NPI 1699909101
$183,846.45
in general payments reported to CMS, 2019-2025
19 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $29K · 2021: $86K · 2022: $33K · 2023: $1,483 · 2024: $4,031 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,445 · Food and Beverage: $1,400 · Travel and Lodging: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,445.00 |
| Food and Beverage | $1,400.10 |
| Travel and Lodging | $873.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $145,836.12 | 2019-2025 | Journey II, Real Intelligence, Legion Revision |
| Arthrex, INC. | $17,100.00 | 2021 | |
| Stryker Corporation | $12,813.15 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $3,159.58 | 2019-2020 | |
| Orthosensor INC. | $1,500.00 | 2020 | |
| Depuy Synthes Sales INC. | $854.33 | 2019-2024 | Monovisc, Orthovisc |
| Innovation Technologies INC | $671.48 | 2021-2024 | Irrisept |
| Abbott Laboratories | $649.44 | 2024 | Cardiomems |
| Orthalign INC | $428.91 | 2019 | |
| Abiomed | $342.22 | 2020-2021 | |
| Medacta USA, INC. | $138.61 | 2020 | |
| Ermi LLC | $108.10 | 2022 | |
| Globus Medical, INC. | $51.59 | 2022-2023 | Evo Retrograde |
| Bone Support INC. | $47.14 | 2019 | |
| Nalu Medical, INC. | $47.13 | 2024 | Nalu Neurostimulation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $32.03 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.31 | 2024 | |
| Heron Therapeutics, INC. | $23.21 | 2025 | Zynrelef |
| Fidia Pharma USA INC. | $19.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.